Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 270,810 shares at $87.56 ($23.7M) on 2021-10-29, disclosed to the SEC on 2021-11-02.
Open-market sale of $23.7M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.56 | 135,405 | $11.9M | 50.0% |
| 2 | $87.56 | 135,405 | $11.9M | 50.0% |
| Total | $87.56 avg | 270,810 | $23.7M | 100% |
| Filing → |
| MRK | SELL | 2026-02-06 | $4.6M | — | Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |